TYVASO DPI (TREPROSTINIL) INHALATION POWDER
Live / Registered — Registered (as of 14 Jun 2022)
What this means for you
Registered since 14 Jun 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90370409
- Registration number
- 6756715
- Mark type
- Design + words
- Filed
- 09 Dec 2020
- Published for opposition
- 29 Mar 2022
- Registered
- 14 Jun 2022
- Attorney of record
- Norm J. Rich
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension and interstitial lung disease, and idiopathic pulmonary fibrosis, where the pharmaceutical preparations contain prostaglandins
Owner
- United Therapeutics Corporation, Silver Spring, MD, US
- United Therapeutics Corporation, Silver Spring, MD, US
- United Therapeutics Corporation, Silver Spring, MD, US
Prior registrations
Prosecution history
- 14 Jun 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 14 Jun 2022 — REGISTERED-PRINCIPAL REGISTER
- 29 Mar 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Mar 2022 — PUBLISHED FOR OPPOSITION
- 09 Mar 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Feb 2022 — NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
- 17 Feb 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Feb 2022 — USE AMENDMENT ACCEPTED
- 16 Feb 2022 — EXAMINER'S AMENDMENT ENTERED
- 16 Feb 2022 — ASSIGNED TO LIE
- 15 Feb 2022 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 15 Feb 2022 — EXAMINERS AMENDMENT E-MAILED
- 15 Feb 2022 — EXAMINERS AMENDMENT -WRITTEN
- 30 Nov 2021 — AMENDMENT TO USE PROCESSING COMPLETE
- 30 Nov 2021 — USE AMENDMENT FILED